Back to Journals » Biologics: Targets and Therapy » Volume 9

Letter

Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

       
Total article views   HTML views PDF downloads Totals
11,089 Dovepress* 10,642+ 1,768 12,410
PubMed Central* 447 156 603
Totals 11,089 1,924 13,013
*Since 19 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar